Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Simris Alg ABOSTO:SIMRIS B +10.19%22 PB Ratio is 28.38 as of Aug. 05, 2026, which is 1049% above its 10-year median of 2.47. GuruFocus rates OSTO:SIMRIS B with a GF Score™ of 22/100 and a GF Value™ of kr0.03 (Significantly Overvalued). The stock has 6 warning signs investors should review. Among 1,228 Biotechnology companies, Simris Alg AB ranks worse than 95.11% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-08-05), Simris Alg AB's share price is kr0.1135. Simris Alg AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr0.00. Hence, Simris Alg AB's PB Ratio of today is 28.38.
Warning Sign:
Simris Alg AB stock PB Ratio (=31.88) is close to 1-year high of 31.88.
The historical rank and industry rank for Simris Alg AB's PB Ratio or its related term are showing as below:
OSTO:SIMRIS B'
s PB Ratio Range Over the Past 10 Years
Min: 0.61 Med: 2.47 Max: 41.83
Current: 28.38
During the past 12 years, Simris Alg AB's highest PB Ratio was 41.83. The lowest was 0.61. And the median was 2.47.
OSTO:SIMRIS B's PB Ratio is ranked worse than 95.11% of 1228
companies
in the Biotechnology industry
Industry Median: 2.85
vs OSTO:SIMRIS B: 28.38
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Simris Alg AB was 47.30% per year. The lowest was -61.10% per year. And the median was -42.65% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Simris Alg AB PB Ratio Related Terms
Simris Alg AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Simris Alg AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
OSTO:SIMRIS B vs VRTX, REGN, RVMD: PB Ratio Comparison
For the Biotechnology subindustry, Simris Alg AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Simris Alg AB PB Ratio vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Simris Alg AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Simris Alg AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Simris Alg AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Simris Alg AB (OSTO:SIMRIS B) has a PB Ratio of 28.38 as of Aug. 05, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Simris Alg AB and its competitors. This is 1049% above median its historical median of 2.47. Over the past decade, Simris Alg AB's PB Ratio has ranged from 0.61 to 41.83. According to the industry distribution chart, Simris Alg AB ranks #1168 out of 1228 companies in the Biotechnology industry, placing it in the top 95.1%.
Is Simris Alg AB's PB Ratio too high?
Simris Alg AB's current PB Ratio of 28.38 is 1049% above median its 10-year median of 2.47. Over the past 10 years, this metric has ranged from a low of 0.61 to a high of 41.83. The Biotechnology industry median PB Ratio is 2.85. Simris Alg AB's value of 28.38 is 895.8% above this industry median. Based on the distribution chart, Simris Alg AB ranks #1168 out of 1228 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Simris Alg AB has a GF Score™ of 22/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Simris Alg AB's PB Ratio compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Simris Alg AB ranks #1168 out of 1228 companies for PB Ratio. This places Simris Alg AB in the lower half of its industry. The industry median PB Ratio is 2.85. Simris Alg AB's value of 28.38 is 895.8% above this benchmark. Historically, Simris Alg AB's own PB Ratio has ranged from 0.61 to 41.83 over the past decade. While the company's 10-year median is 2.47 vs. the industry median of 2.85, Simris Alg AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Biotechnology company?
The median PB Ratio among Biotechnology companies is 2.85, based on 1,228 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Simris Alg AB's current PB Ratio of 28.38 is 895.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Simris Alg AB and its competitors. For the Biotechnology industry, the median PB Ratio is 2.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Simris Alg AB's current PB Ratio is 28.38, which is 1049% above median its own 10-year median of 2.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Simris Alg AB stock overvalued right now?
Based on GuruFocus' analysis, Simris Alg AB (OSTO:SIMRIS B) is currently considered Significantly Overvalued. The stock's GF Value™ is kr0.03, compared to a current price of kr0.11 — trading 278.3% above its estimated fair value. The current PB Ratio is 28.38, which is 1049% above median its 10-year median of 2.47 and 895.8% above the Biotechnology industry median of 2.85. Simris Alg AB's overall GF Score™ is 22/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Simris Alg AB (OSTO:SIMRIS B), the current PB Ratio is 28.38 as of Aug. 05, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Simris Alg AB (OSTO:SIMRIS B) Overvalued in 2026?
Based on GuruFocus' analysis, Simris Alg AB stock appears to be overvalued.
The current stock price of kr0.11 is trading 278.3% above its estimated GF Value™ of kr0.03.
GuruFocus considers Simris Alg AB to be Significantly Overvalued.
Key valuation signals for OSTO:SIMRIS B:
PB Ratio: 28.38 (1049% above median its 10-year median of 2.47)
GF Value™: kr0.03 vs. price of kr0.11 (278.3% above fair value)
Industry Position: 895.8% above the Biotechnology median (#1168 of 1228)
No single metric tells the full story. See the OSTO:SIMRIS B stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Simris Alg AB is a biotechnology company, engaged in research, development and production of bioactive substances from microalgae, for nutraceutical, cosmeceutical and pharmaceutical applications. The company's technology provides access to bioactive substances with novel functions, while replacing unsustainable raw materials from endangered marine species and ecosystems. Its first commercialised range is a series of omega-3 health supplements marketed under the company's own brand.
22GF Score
Get the complete analysis for OSTO:SIMRIS B
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:SIMRIS B has been successfully added to your 
